Fellow Scientist
Regeneron Pharmaceuticals Inc
Tarrytown
Dr. Ching Ha (Vicky) Lai is a Fellow Scientist in Bioanalytical Sciences Department at Regeneron. In her current role, she serves as a subject matter expert in regulated bioanalysis and immunogenicity for clinical programs across different therapeutic areas. Dr. Lai has supported more than 10 programs from early clinical phase to post-marketing stage and has been involved in multiple global regulatory submissions. Her interests pertain to immunogenicity from risk assessment to clinical impact on PK/PD. Prior to Regeneron, she served as Research Investigator at Novartis and Principal Scientist at Valeant Pharmaceuticals International, where her group was responsible for anti-viral drug development from discovery to late-phase clinical development. She earned her doctoral degree from the Chinese University of Hong Kong and completed her postdoctoral training at Merck (formerly Schering Plough Research Institute).
Disclosure information not submitted.
Hot Topic: Navigating the New FDA Immunogenicity Labelling Guidance
Thursday, May 16, 2024
2:00 PM – 3:00 PM PT